Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Adherence to pharmacological treatment in non-communicable chronic diseases in the Colombian population: Systematic review and meta-analysis ; Cumplimiento del tratamiento farmacológico en enfermedades crónicas no transmisibles en la población colombiana: revisión sistemática y metaanálisis

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • بيانات النشر:
      Instituto Nacional de Salud
    • الموضوع:
      2023
    • Collection:
      Biomédica - Revista del Instituto Nacional de Salud, Bogotá
    • نبذة مختصرة :
      Introduction. Non-communicable chronic diseases represent the leading cause of death worldwide, and their prevalence is increasing due to the epidemiological transition. Despite the advances in their management, control rates are deficient, attributed to multiple factors like adherence to pharmacological treatment, one of the most significant and least studied in the Colombian population.Objective. To calculate adherence to treatment in Colombian patients with arterial hypertension, cerebrovascular disease, diabetes mellitus, asthma, chronic obstructive pulmonary disease, and dyslipidemia between 2005 and 2022.Materials and methods. We performed a systematic literature review and a meta-analysis of studies identified through the Medline and LILACS databases to quantitatively synthesize treatment adherence percentage.Results. Fourteen studies met the inclusion criteria, and 5,658 patients were analyzed. The treatment adherence was 59%, with significant heterogeneity among the included studies (95% CI= 46- 71%; I2 = 98.8%, p< 0.001). Higher adherence rates were observed for diabetes mellitus (79%; 95% CI = 65- 90%) and dyslipidemia (70%; 95% CI = 66- 74%). Adherence to arterial hypertension treatment was 51% (95 %; CI = 31- 72%).Conclusions. This systematic review showed low adherence to recommendations regarding pharmacological management in non-communicable chronic diseases, which can have implications for long-term clinical outcomes and disease burden. ; Introducción. Las enfermedades crónicas no transmisibles representan la principal causa de muerte en el mundo y su prevalencia va en aumento debido a la transición epidemiológica. A pesar de los avances en su manejo, las cifras de control son deficientes y esto se atribuye a múltiples factores, como el cumplimiento del tratamiento farmacológico, que es uno de los más representativos y menos estudiados en la población colombiana.Objetivo. Establecer la frecuencia de casos que cumplieron con el tratamiento farmacológico en pacientes colombianos con ...
    • File Description:
      application/pdf; text/xml
    • Relation:
      https://revistabiomedica.org/index.php/biomedica/article/view/7077/5417; https://revistabiomedica.org/index.php/biomedica/article/view/7077/5473; https://revistabiomedica.org/index.php/biomedica/article/view/7077/5407; Centers for Disease Control and Prevention. About Global NCDs. Fecha de consulta: 18 de febrero 2023. Disponible en: https://www.cdc.gov/globalhealth/healthprotection/ncd/globalncd-overview.html; Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442. https://doi.org/10.1371/journal.pmed.0030442; GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659-724. https://doi.org/10.1016/S0140-6736(16)31679-8; Our World in Data. Disease burden from non-communicable diseases, world, 1990 to 2019. Fecha de consulta: 18 de febrero 2023. Disponible en: https://ourworldindata.org/grapher/disease-burden-from-ncds; World Health Organization. Global status report on noncommunicable diseases 2010. Fecha de consulta: 18 de febrero 2023. Disponible en: https://apps.who.int/iris/handle/10665/44579; Bigna JJ, Noubiap JJ. The rising burden of non-communicable diseases in sub-Saharan Africa. Lancet Glob Health. 2019;7:e1295-e6. https://doi.org/10.1016/S2214-109X(19)30370-5; Posso MB, Ruiz PA, Ramírez CC, Mantilla ÁJ, Parra-Gómez LA, Rocha C, et al. Sindemia y enfermedades crónicas no transmisibles. Una perspectiva social y biológica. SFJ of Health. 2022;3:317-27. https://doi.org/10.46981/sfjhv3n3-011; World Health Organization. The impact of the COVID-19 pandemic on noncommunicable disease resources and services: results of a rapid assessment. Fecha de consulta: 18 de febrero 2023. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/334136/9789240010291-eng.pdf; Budreviciute A, Damiati S, Sabir DK, Onder K, Schuller-Goetzburg P, Plakys G, et al. Management and prevention strategies for non-communicable diseases (NCD) and their risk factors. Front Public Health. 2020;8:574111. https://doi.org/10.3389/fpubh.2020.574111; Egede LE, Gebregziabher M, Echols C, Lynch CP. Longitudinal effects of medication nonadherence on glycemic control. Ann Pharmacother. 2014;48:562-70. https://doi.org/10.1177/1060028014526362; Organización Mundial de la Salud. Determinantes sociales de la salud en la Región de las Américas. Fecha de consulta: 20 de febrero 2023. Disponible en: https://www.paho.org/salud-en-las-americas-2017/uh-determinants-es.html; Mendoza R. La adherencia terapéutica en pacientes con enfermedades crónicas no transmisibles: diabetes, hipertensión y obesidad. Medicina y Ética. 2021;32:897-921. https://doi.org/10.36105/mye.2021v32n4.01; Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71; World Health Organization. Adherence to long-term therapies. Fecha de consulta: 20 de febrero 2023. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf?sequence=1&isAllowed=y; Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. https://doi.org/10.1186/s13643-016-0384-4; Von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J. Declaración de la iniciativa STROBE (Strengthening the Reporting of Observational studies in Epidemiology): directrices para la comunicación de estudios observacionales. Rev Esp Salud Publica. 2008;82:251-9.; Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. Joanna Briggs Institute Reviewer’s Manual. The Joanna Briggs Institute, 2017. https://doi.org/10.46658/JBIMES-20-08; Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88. https://doi.org/10.1016/0197-2456(86)90046-2; Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stats. 1950;21:607-11.; Nyaga VN, Arbyn M, Aerts M. Metaprop: A Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72:39. https://doi.org/10.1186/2049-3258-72-39; Barker TH, Migliavaca CB, Stein C, Colpani V, Falavigna M, Aromataris E, et al. Conducting proportional meta-analysis in different types of systematic reviews: A guide for synthesizers of evidence. BMC Med Res Methodol. 2021;21. https://doi.org/10.1186/s12874-021-01381-z; Ospina JM, Martínez LJ, Ospina LV, Bueno SJ, Gutiérrez HH, Camacho PA. Compliance to treatment in diabetic patients from Bucaramanga, Colombia: A cross sectional study. Arch Med (Manizales). 2019;19:32-45. https://doi.org/10.30554/archmed.19.1.2877.2019; Falun DJ, Villegas JD, Cardona J, Cardona S, Quintero S, Castrillón JD, et al. Clínica y tratamiento de la diabetes tipo 2 en adultos jóvenes en un hospital colombiano. Acta Med Colomb. 2021;46:19-24. https://doi.org/10.36104/amc.2021.1902; Rodríguez MR, Varela MT, Rincón H, Velasco MM, Caicedo DM, Méndez F, et al. Prevalencia y factores asociados a la adherencia al tratamiento no farmacológico en pacientes con hipertensión y diabetes en servicios de baja complejidad. Rev Fac Nac Salud Pública. 2015;33:192-9. https://doi.org/10.17533/udea.rfnsp.v33n2a06; Martínez GI, Martínez LM, Rodríguez MA, Agudelo CA, Jiménez JG, Vargas N, et al. Adherencia terapéutica y control metabólico en pacientes con diabetes mellitus tipo 2, pertenecientes a una institución hospitalaria, de la ciudad de Medellín (Colombia), Año 2011. Arch Med (Manizales). 2014;14:44-50. https://doi.org/10.30554/archmed.14.1.240.2014; Machado JE, Murillo MM, Machado ME. Effectiveness of lipid-lowering therapy among a sample of patients in Colombia. Rev Panam Salud Pública. 2013;33:383-90; Arciniegas W, Bolívar F, Cano DJ. Evaluación de costos de un programa de oxigenoterapia domiciliaria. Salud. 2010;42:48-54.; Quiroz SP, Agudelo DM, Lucumi DI, Mentz G. Asociación entre marcadores de posición social y adherencia al tratamiento de la hipertensión arterial en Colombia. Rev Chil Salud Pública. 2020;24:11–22. https://doi.org/10.5354/0719-5281.2020.57581; Guarín GM, Pinilla AE. Adherencia al tratamiento antihipertensivo y su relación con la calidad de vida en pacientes de dos hospitales de Bogotá, D.C. 2013-2014. Rev Fac Med Univ Nac Colomb. 2016;64:651-7. https://doi.org/10.15446/revfacmed.v64n4.52217; Benavides VA, Jaramillo L, Rendón SM, Valenzuela AM, Argotty E, Mafla AC. Determinantes de adherencia al tratamiento antihipertensivo de adultos ≥ 35 años de edad. Salud. 2013;15: 23-135.; Casas MC, Chavarro LM, Cardona D. Adhesión al tratamiento de la hipertensión arterial en dos municipios de Colombia, 2010-2011. Hacia Promoc Salud. 2013;18:81-96.; Castaño JJ, Echeverri C, Giraldo JF, Maldonado A, Melo J, Meza GA et al. Adherencia al tratamiento de pacientes hipertensos atendidos en Assbasalud ESE, Manizales (Colombia) 2011. Rev Fac Med. 2012;60:179-97.; Martínez JW, Villa JA, Quintero AM, Jaramillo J, Calderón V, Copete AV. Frecuencia de factores de riesgo cardiovascular en pacientes hipertensos en un hospital de segundo nivel. Rev Fac Nac Salud Pública. 2011;29. https://doi.org/10.17533/udea.rfnsp.5246; Herrera R, Badiel M, Zapata H. Factores asociados al no control de la presión arterial en pacientes inscritos al programa de hipertensión de una Entidad Promotora de Salud en Cali-Colombia, 2004. Rev Colomb Cardiol. 2009;16:143-52.; Camacho PA, Gómez D, Otero J, González S, Molina DI, Sánchez G, et al. Self-reported prevalence of chronic non-communicable diseases in relation to socioeconomic and educational factors in Colombia: A community-based study in 11 departments. Glob Heart. 2020;15:35. https://doi.org/10.5334/gh.792; Lemstra M, Nwankwo C, Bird Y, Moraros J. Primary nonadherence to chronic disease medications: A meta-analysis. Patient Prefer Adherence. 2018;12:721-31. https://doi.org/10.2147/PPA.S161151; Piragine E, Petri D, Martelli A, Calderone V, Lucenteforte E. Adherence to oral antidiabetic drugs in patients with type 2 diabetes: systematic review and meta-analysis. J Clin Med. 2023;12:1981. https://doi.org/10.3390/jcm12051981; Franchi C, Ludergnani M, Merlino L, Nobili A, Fortino I, Leoni O, et al. Multiple medication adherence and related outcomes in community-dwelling older people on chronic polypharmacy: a retrospective cohort study on administrative claims data. Int J Environ Res Public Health. 2022;19:5692. https://doi.org/10.3390/ijerph19095692; Azharuddin M, Adil M, Sharma M, Gyawali B. A systematic review and meta-analysis of nonadherence to anti-diabetic medication: Evidence from low- and middle-income countries. Int J Clin Pract. 2021;75:e14717. https://doi.org/10.1111/ijcp.14717; Lemstra M, Blackburn D, Crawley A, Fung R. Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis. Can J Cardiol. 2012;28:574-80. https://doi.org/10.1016/j.cjca.2012.05.007; Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine (Baltimore). 2017;96:e5641. https://doi.org/10.1097/MD.0000000000005641; Nielsen JØ, Shrestha AD, Neupane D, Kallestrup P. Non-adherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects. J Hum Hypertens. 2017;31:14-21. https://doi.org/10.1038/jhh.2016.31; Lemstra M, Alsabbagh MW. Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis. Patient Prefer Adherence. 2014;8:211-8. https://doi.org/10.2147/PPA.S55382; Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MC, Verhamme KM. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015 45:396-407. https://doi.org/10.1183/09031936.00075614; George M, Bender B. New insights to improve treatment adherence in asthma and COPD. Patient Prefer Adherence. 2019;13:1325-34. https://doi.org/10.2147/PPA.S209532; Świątoniowska N, Chabowski M, Polański J, Mazur G, Jankowska-Polańska B. Adherence to therapy in chronic obstructive pulmonary disease: a systematic review. Adv Exp Med Biol. 2020;1271:37-47. https://doi.org/10.1007/5584_2019_477; Zhang J, Gong Y, Zhao Y, Jiang N, Wang J, Yin X. Post-stroke medication adherence and persistence rates: a meta-analysis of observational studies. J Neurol. 2021;268:2090-8. https://doi.org/10.1007/s00415-019-09660-y; Cárdenas LP. Validación de la escala “Morisky Medication Adherence (mmas8)” en pacientes hipertensos inscritos en el programa de riesgo cardiovascular en la ciudad de Santa Marta. Santa Marta: Universidad de Magdalena; 2021. https://repositorio.unimagdalena.edu.co/items/68db1f4b-b9d4-4619-abc2-77762afb97bb/full; Chaves NM, Echeverri JE, Ballesteros DA, Quijano J, Camacho D. Validación de la escala de Morisky de 8 ítems en pacientes con enfermedad renal crónica. Rev Med. 2016;24:23-32. https://doi.org/10.18359/rmed.2627; Conn VS, Ruppar TM, Chase JA, Enriquez M, Cooper PS. Interventions to improve medication adherence in hypertensive patients: systematic review and meta-analysis. Curr Hypertens Rep. 2015;17:94. https://doi.org/10.1007/s11906-015-0606-5; Varela MT. El reto de evaluar la adherencia al tratamiento en la hipertensión arterial. Pensamiento Psicológico. 2010;7:127-39.; Pandey A, Raza F, Velasco A, Brinker S, Ayers C, Das SR, et al. Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatmentresistant hypertension. J Am Soc Hypertens. 2015;9:420-6.e2. https://doi.org/10.1016/j.jash.2015.04.004; Burnier M. Drug adherence in hypertension. Pharmacol Res. 2017;125:1429. https://doi.org/10.1016/j.phrs.2017.08.015; Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957-67. https://doi.org/10.1016/S0140-6736(15)01225-8; Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication non-adherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836-41. https://doi.org/10.1001/archinte.166.17.1836; Buckley L, Labonville S, Barr J. A systematic review of beliefs about hypertension and its treatment among African Americans. Curr Hypertens Rep. 2016;18:52. https://doi.org/10.1007/s11906-016-0662-5; Lewis LM. Factors associated with medication adherence in hypertensive blacks: a review of the literature. J Cardiovasc Nurs. 2012;27:208-19. https://doi.org/10.1097/JCN.0b013e318215bb8f; Legido H, Camacho PA, Balabanova D, Perel P, Lopez P, Nieuwlaat R, et al. Patients’ knowledge, attitudes, behaviour and health care experiences on the prevention, detection, management and control of hypertension in Colombia: a qualitative study. PLoS One. 2015;10:e0122112. https://doi.org/10.1371/journal.pone.0122112; Gwadry FH, Manias E, Lal L, Salas M, Hughes DA, Ratzki A, et al. Impact of interventions on medication adherence and blood pressure control in patients with essential hypertension: a systematic review by the ISPOR medication adherence and persistence special interest group. Value Health. 2013;16:863-71. https://doi.org/10.1016/j.jval.2013.03.1631; Hassan TA, Sáenz JE, Ducinskiene D, Cook JP, Imperato JS, Zou KH. New strategies to improve patient adherence to medications for noncommunicable diseases during and after the COVID-19 era identified via literature review. J Multidiscip Health. 2021;14:2453-65. https://doi.org/10.2147/JMDH.S313626; https://revistabiomedica.org/index.php/biomedica/article/view/7077
    • Rights:
      Derechos de autor 2023 Biomédica ; https://creativecommons.org/licenses/by/4.0
    • الرقم المعرف:
      edsbas.5190EA5E